ICPOC 2026, the 2nd Edition of the International Cancer and Precision Oncology Conference, scheduled November 23-25, 2026, in Singapore, will feature online and hybrid participation for international attendees. This gathering provides a forum for exploring the latest innovations in individualized cancer management. The Precision Oncology Conference focuses on bridging research and clinical practice to improve patient-centered outcomes. Participants will engage with adaptive care models, translational integration methods, and evidence-based treatment frameworks designed to enhance clinical decision-making across diverse healthcare settings. Agenda topics include personalized therapy development, analytical evaluation frameworks, implementation-focused methodologies, innovation-guided clinical systems, and outcome-oriented planning. Sessions are designed to promote practical application in modern oncology practice. Interactive panels and workshops provide opportunities to analyze case studies, review emerging methodologies, and discuss operational and regulatory considerations affecting treatment adaptation. Collaborative exchanges encourage interdisciplinary networking and foster partnerships that advance precision oncology globally. ICPOC 2026 also emphasizes the integration of novel diagnostics, targeted therapeutic strategies, and translational innovation into everyday clinical workflows. Presentations deliver actionable insights to enhance efficiency, efficacy, and patient safety while promoting sustainable healthcare improvement. Attendees will gain exposure to advanced care models, research-driven approaches, and innovative clinical strategies that support patient-specific treatment planning. The Cancer Conference strengthens international collaboration and fosters professional development across healthcare, academic, and technological sectors. By combining physical attendance with remote participation opportunities, ICPOC 2026 ensures accessibility and flexibility. The Upcoming Oncology Conferences equips professionals with knowledge, practical tools, and collaborative networks that can drive the future of precision-guided oncology worldwide.